Acute Respiratory Distress Syndrome and Posterior Reversible Encephalopathy Syndrome following Rituximab Therapy

The anti-CD20 monoclonal antibody rituximab is associated with rare but significant adverse events, notably posterior reversible encephalopathy syndrome (PRES) and acute respiratory distress syndrome (ARDS). We report a case of concomitant ARDS and PRES developing after rituximab therapy for treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Wardrope, Katrina E., Manson, Lynn, Metcalfe, Wendy, Sullivan, Eoin D. O
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2016
Materias:
Published online: February, 2016
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4886031/
https://www.ncbi.nlm.nih.gov/pubmed/27275457
http://dx.doi.org/10.1159/000444250

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4886031/
https://www.ncbi.nlm.nih.gov/pubmed/27275457
http://dx.doi.org/10.1159/000444250

Ejemplares similares